Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dieda Fengshi Yaojiu is a traditional Chinese medicine (TCM) medicinal wine developed and manufactured by Guiyang Dechangxiang Pharmaceutical. It is an approved product in China formulated to address conditions related to traumatic injuries and rheumatic disorders. In the framework of traditional Chinese medicine, the preparation is designed to dispel wind, remove dampness, promote blood circulation, and alleviate pain. It is typically used for the treatment of rheumatic bone pain, joint swelling, and pain resulting from falls, bruises, or sprains. The product is created by macerating a complex blend of herbal ingredients in an alcohol base, which serves both as a solvent for the active constituents and as a vehicle to enhance systemic absorption and local circulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dieda Fengshi Yaojiu.